Search results for "Arsenicals"
showing 10 items of 25 documents
Ochrobactrum sp. MPV1 from a dump of roasted pyrites can be exploited as bacterial catalyst for the biogenesis of selenium and tellurium nanoparticles
2017
Bacteria have developed different mechanisms for the transformation of metalloid oxyanions to non-toxic chemical forms. A number of bacterial isolates so far obtained in axenic culture has shown the ability to bioreduce selenite and tellurite to the elemental state in different conditions along with the formation of nanoparticles—both inside and outside the cells—characterized by a variety of morphological features. This reductive process can be considered of major importance for two reasons: firstly, toxic and soluble (i.e. bioavailable) compounds such as selenite and tellurite are converted to a less toxic chemical forms (i.e. zero valent state); secondly, chalcogen nanoparticles have att…
Arsenic exposure, diabetes-related genes and diabetes prevalence in a general population from Spain.
2018
Inorganic arsenic exposure may be associated with diabetes, but the evidence at low-moderate levels is not sufficient. Polymorphisms in diabetes-related genes have been involved in diabetes risk. We evaluated the association of inorganic arsenic exposure on diabetes in the Hortega Study, a representative sample of a general population from Valladolid, Spain. Total urine arsenic was measured in 1,451 adults. Urine arsenic speciation was available in 295 randomly selected participants. To account for the confounding introduced by non-toxic seafood arsenicals, we designed a multiple imputation model to predict the missing arsenobetaine levels. The prevalence of diabetes was 8.3%. The geometric…
Biology and management of therapy-related acute promyelocytic leukemia.
2013
Therapy-related acute promyelocytic leukemia (t-APL) has been increasingly reported after exposure to cytotoxic and/or immunosuppressive agents given for prior malignancies or autoimmune diseases. t-APL represents both a model for better understanding human leukemogenesis and an interesting therapeutic subset which requires specific adaptations for optimal management.We discuss here potential risk factors for t-APL development and the main biologic and clinical characteristics of t-APL as compared to de-novo APL.In addition, we review therapeutic results obtained in patients with t-APL receiving conventional retinoic acid and chemotherapy and discuss new treatment opportunities with minimal…
First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic…
2017
Recently, studies in adults with acute promyelocytic leukemia (APL) showed high cure rates in low-risk patients treated with all-trans retinoid acid (ATRA) and arsenic trioxide (ATO), while toxicities were significantly reduced compared to the standard treatment with ATRA and chemotherapy. Here we report about first experience with 11 pediatric patients with low-risk APL treated with ATRA and ATO. All patients stayed in molecular remission. All suffered from hyperleukocytosis. Two patients experienced reversible severe side effects. One suffered from osteonecroses at both femurs, seizures, as well as posterior reversible encephalopathy syndrome, the other patient had an abducens paresis.
How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia
2014
Abstract Differentiation syndrome (DS), formerly known as retinoic acid syndrome, is a relatively common and potentially severe complication seen in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and/or arsenic trioxide. The full-blown syndrome consists of unexplained fever, weight gain, dyspnea with pulmonary infiltrates, pleuropericardial effusion, hypotension, and renal failure. Most measures currently used for management of DS have very little evidence-based support, and therefore, many remain controversial. Despite the lack of evidence supporting DS prophylaxis, several groups have adopted a preventive strategy with corticosteroids, especially for patie…
Multioctave midinfrared supercontinuum generation in suspended-core chalcogenide fibers
2014
An As2S3 fiber-based supercontinuum source that covers 3500 nm, extending from near visible to the midinfrared, is successfully reported by using a 200-fs-pulsed pump with nJ-level energy at 2.5 μm. The main features of our fiber-based source are two-fold. On the one hand, a low-loss As2S3 microstructured optical fiber has been fabricated, with typical attenuation below 2 dB/m in the 1-4 μm wavelength range. On the other hand, a 20-mm-long microstructured fiber sample is sufficient to enable a spectral broadening, spreading from 0.6 to 4.1 μm in a 40 dB dynamic range.
Microstructured chalcogenide optical fibers from As2S3 glass: towards new IR broadband sources
2010
Made available in DSpace on 2013-08-28T14:12:29Z (GMT). No. of bitstreams: 1 WOS000285749500124.pdf: 1017839 bytes, checksum: f517fd8ef33fd56d66b9ccda9dc4d0f3 (MD5) Made available in DSpace on 2013-09-30T19:22:53Z (GMT). No. of bitstreams: 2 WOS000285749500124.pdf: 1017839 bytes, checksum: f517fd8ef33fd56d66b9ccda9dc4d0f3 (MD5) WOS000285749500124.pdf.txt: 33157 bytes, checksum: 1ca2ac713bf6024674249abf58520bcb (MD5) Previous issue date: 2010-12-06 Submitted by Vitor Silverio Rodrigues (vitorsrodrigues@reitoria.unesp.br) on 2014-05-20T15:34:00Z No. of bitstreams: 2 WOS000285749500124.pdf: 1017839 bytes, checksum: f517fd8ef33fd56d66b9ccda9dc4d0f3 (MD5) WOS000285749500124.pdf.txt: 33157 bytes,…
Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours.
2009
Scientific progress in genetics, cell and molecular biology has greatly ameliorated our comprehensive understanding of the molecular mechanisms of neoplastic transformation and progression. The rapidly advancing identification of molecular targets in human cancers during the last decade has provided an excellent starting point for the development of novel therapeutics. A huge variety of potential molecular targets have been identified, many of which are already in the market for therapeutic purposes. It is now becoming possible to target pathways and/or molecules that are crucial in maintaining the malignant phenotype. Traditional Chinese medicine (TCM) is often considered as alternative or…
Non-chromatographic speciation of toxic arsenic in vegetables by hydride generation-atomic fluorescence spectrometry after ultrasound-assisted extrac…
2007
A non-chromatographic, sensitive and simple analytical method has been developed for the determination of toxic arsenic species in vegetable samples by hydride generation-atomic fluorescence spectrometry (HG-AFS). As(III), As(V), dimethylarsinic acid (DMA) and monomethylarsonic acid (MMA) were determined by hydride generation-atomic fluorescence spectrometry using a series of proportional equations. The method is based on a single extraction of the arsenic species considered from vegetables through sonication at room temperature with H(3)PO(4) 1 mol L(-1) in the presence of 0.1% (w/v) Triton XT-114 and washing of the solid phase with 0.1% (w/v) EDTA, followed by direct measurement of the co…
Exposure and risk assessment to arsenic species in Spanish children using biomonitoring
2018
We present a new approach to arsenic (As) risk assessment using biomonitoring. In this pilot study we determined the levels of total and speciated urinary arsenicin 109 Spanish school children aged between 6 and 11 years, and interpreted these concentrations in a risk assessment context. The geometric mean (GM) for total As (TAs) was 33.82 mu/L. The order of occurrence and average concentrations of the different species was arsenobetaine (AsB) (100%, 15 mu g/L), dimethylarsinic (DMA) (97%, 8.32 mu g/L), monomethylarsonic (MMA) (26%, 027 mu g/L) and inorganic As (iAs) (4%, 0.14 mu g/L). 18% of children presented exposures to inorganic arsenic (7.52 mu g/g creatinine) higher than guidance val…